| abstract |
A selective novel compounds breast cancer resistant protein (BCRP), the A compounds FUN-4 represented by the following formula to provide a nuclear medicine diagnostic agents, including their preparation and the compounds 18 F We succeeded in developing PET drug labeled with [ 18 F] FUN-4, and by using this compound, we found that compound FUN-4 is a substrate compound selective for BCRP. [Selection figure] None |